Author

Yoshimasa Miyagawa

Observed names: MIYAGAWA, Yoshimasa, Miyagawa, Yoshimasa, Y Miyagawa, YOSHIMASA MIYAGAWA

Observed institutions: Hyogo Medical University, Aichi Medical University, Aichi Medical University Hospital, Nagoya Ekisaikai Hospital, Japanese Urological Association, Gamagori City Hospital, Tokushima University

OpenAlex ID: A5110178751

Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel

2018 · Kazuhiro Araki, Yoshinori Ito, et al. · BMC Cancer · 63

PDF

Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel

2018 · Yoshimasa Miyagawa, Kazuhiro Araki, et al. · Clinical Breast Cancer · 55

High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer

2014 · Arisa Nishimukai, Tomoko Yagi, et al. · Clinical Breast Cancer · 49

Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes

2016 · Tomoko Higuchi, Arisa Nishimukai, et al. · The Breast · 44

Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine

2019 · Michiko Imamura, Takashi Morimoto, et al. · Scientific Reports · 36

PDF

Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers

2019 · Yukie Fujimoto, Takahiro Watanabe, et al. · Breast Cancer · 35

Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes

2018 · Michiko Imamura, Takashi Morimoto, et al. · World Journal of Surgical Oncology · 30

PDF

Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER+, and HER2− Breast Cancer

2014 · Ayako Yanai, Natsuko Inoue, et al. · Clinical Breast Cancer · 27

Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers

2015 · Yukie Enomoto, Takashi Morimoto, et al. · International Journal of Clinical Oncology · 26

Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers

2014 · Tomoko Yagi, Natsuko Inoue, et al. · Breast Cancer · 24

Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in 18F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy

2019 · Tomoko Higuchi, Yukie Fujimoto, et al. · Annals of Surgical Oncology · 23

PDF

Improved prognosis of low baseline neutrophil‑to‑lymphocyte ratio is significantly exclusive in breast cancer patients with high absolute counts of lymphocytes

2018 · Yukie Fujimoto, Hiromi Ozawa, et al. · Molecular and Clinical Oncology · 22

PDF

Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating Lymphocytes

2020 · AYAKO BUN, YUKIE FUJIMOTO, et al. · Anticancer Research · 21

PDF

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer

2020 · Yoshimasa Miyagawa, Ayako Yanai, et al. · Oncotarget · 21

PDF

C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With Eribulin

2020 · ATSUSHI SATA, REIKO FUKUI, et al. · Anticancer Research · 20

PDF

Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers

2013 · Ayako Yanai, Yoshimasa Miyagawa, et al. · International Journal of Clinical Oncology · 19

Frequent downregulation of LRRC26 by epigenetic alterations is involved in the malignant progression of triple-negative breast cancer

2018 · Yoshimasa Miyagawa, Yosuke Matsushita, et al. · International Journal of Oncology · 15

PDF

Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women

2013 · Yoshimasa Miyagawa, Tomohiro Miyake, et al. · Breast Cancer · 14

High levels of serum CA15‐3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non‐pathological complete response after neoadjuvant chemotherapy

2018 · Yukie Fujimoto, Tomoko Higuchi, et al. · Journal of Surgical Oncology · 13

Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers

2012 · Keiko Murase, Ayako Yanai, et al. · Breast Cancer · 12

Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases

2016 · Arisa Nishimukai, Tomoko Higuchi, et al. · Breast Cancer · 10

A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site

2019 · HIROMI OZAWA, ATSUSHI SATA, et al. · Anticancer Research · 9

PDF

Serum Prostate‐Specific Antigen Values for the Prediction of Clinical Stage and Prognosis in Patients with Prostate Cancer: An Analysis of 749 Cases

1996 · Manabu Kuriyama, Koji Obata, et al. · International Journal of Urology · 9

PDF

High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients

2015 · Michiko Imamura, Arisa Nishimukai, et al. · Breast Cancer Research and Treatment · 7

C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis

2013 · Tomohiro Miyake, Takashi Ito, et al. · Breast Cancer · 7

Works count: 41

Citation count: 625

H-index: 16

I10-index: 21